Cargando…
Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes
Hereditary breast cancer syndromes affect a small (10–15% of cases) but significant group of patients. BRCA1 and BRCA2 are the most familiar and well-studied genes associated with inherited breast cancer. However, mutations in the high-penetrance genes, TP53, PTEN, CDH1, MSH1, MLH1, MSH6, PMS2, PALB...
Autores principales: | Peleg Hasson, Shira, Menes, Tehillah, Sonnenblick, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394592/ https://www.ncbi.nlm.nih.gov/pubmed/32801835 http://dx.doi.org/10.2147/PGPM.S233485 |
Ejemplares similares
-
The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer
por: Bar, Yael, et al.
Publicado: (2021) -
Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
por: Menes, Tehillah S., et al.
Publicado: (2021) -
Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis
por: Peleg Hasson, S., et al.
Publicado: (2021) -
Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
por: Peleg Hasson, S., et al.
Publicado: (2021) -
Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?
por: Stern, Tomer, et al.
Publicado: (2021)